Therapeutic uses for Angiotensin-(1-7)

被引：27
|
作者：
Machado-Silva, Alice [1 ]
Passos-Silva, Danielle [2 ]
Santos, Robson Augusto [2 ]
Sinisterra, Ruben Dario [3 ]
机构：
[1] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2016年 / 26卷 / 06期
关键词：
Angiotensin (1-7); Arg0; Mas receptor; PanCyte; TXA-127; RAS; IMPROVES LIPID-METABOLISM; ORAL FORMULATION; SKELETAL-MUSCLE; ENZYME; MAS; SYSTEM; BRAIN; INFLAMMATION; INHIBITION; PEPTIDE;
D O I：
10.1080/13543776.2016.1179283
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Introduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.
引用
收藏
页码：669 / 678
页数：10
相关论文
共 50 条
  • [1] Angiotensin-(1-7)
    Santos, Robson Augusto
    HYPERTENSION, 2014, 63 (06) : 1138 - 1147
  • [2] Angiotensin-(1-7): an update
    Santos, RAS
    Campagnole-Santos, MJ
    Andrade, SP
    REGULATORY PEPTIDES, 2000, 91 (1-3) : 45 - 62
  • [3] Angiotensin-(1-7) in hypertension
    Chappell, MC
    Ferrario, CM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (02): : 231 - 235
  • [4] Angiotensin-(1-7), Adipokines and Inflammation
    Lelis, Deborah de Farias
    de Freitas, Daniela Fernanda
    Machado, Amanda Souto
    Crespo, Thaisa Soares
    Sousa Santos, Sergio Henrique
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 95 : 36 - 45
  • [5] Antihypertensive effects of angiotensin-(1-7)
    Chappell, MC
    Iyer, SN
    Diz, DI
    Ferrario, CM
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (09) : 1205 - 1212
  • [6] Angiotensin-(1-7): Vasodilator or antagonist?
    Forster, C
    LeTran, Y
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P43 - P43
  • [7] Renal actions of angiotensin-(1-7)
    SimoeseSilva, AC
    Baracho, NCV
    Passaglio, KT
    Santos, RAS
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1997, 30 (04) : 503 - 513
  • [8] NEUROPHYSIOLOGICAL RESPONSES TO ANGIOTENSIN-(1-7)
    FELIX, D
    KHOSLA, MC
    BARNES, KL
    IMBODEN, H
    MONTANI, B
    FERRARIO, CM
    HYPERTENSION, 1991, 17 (06) : 1111 - 1114
  • [9] Counterregulatory actions of angiotensin-(1-7)
    Ferrario, CM
    Chappell, MC
    Tallant, EA
    Brosnihan, KB
    Diz, DI
    HYPERTENSION, 1997, 30 (03) : 535 - 541
  • [10] Angiotensin-(1-7) and antihypertensive mechanisms
    Ferrario, CM
    JOURNAL OF NEPHROLOGY, 1998, 11 (06) : 278 - 283
12345